These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32965155)

  • 1. Serial Detection of
    Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
    Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
    Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
    Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
    Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
    Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
    Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
    Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
    [No Abstract]   [Full Text] [Related]  

  • 7. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
    Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular chemotherapy for vitreoretinal lymphoma: A review.
    Kvopka M; Lake SR; Smith JR
    Clin Exp Ophthalmol; 2020 Mar; 48(2):240-248. PubMed ID: 31680408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
    Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
    Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
    Habot-Wilner Z; Frenkel S; Pe'er J
    Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence.
    Park YG; Park WK; Kim RY; Kim M; Park YH
    Sci Rep; 2020 Oct; 10(1):15992. PubMed ID: 33009434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.
    Pulido JS; Salomao DR; Frederick LA; Viswanatha DS
    Retina; 2015 Apr; 35(4):624-7. PubMed ID: 25768255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
    Raja H; Salomão DR; Viswanatha DS; Pulido JS
    Retina; 2016 Mar; 36(3):624-8. PubMed ID: 26900675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.
    Bonzheim I; Giese S; Deuter C; Süsskind D; Zierhut M; Waizel M; Szurman P; Federmann B; Schmidt J; Quintanilla-Martinez L; Coupland SE; Bartz-Schmidt KU; Fend F
    Blood; 2015 Jul; 126(1):76-9. PubMed ID: 25900979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation.
    Carreno E; Clench T; Steeples LR; Salvatore S; Lee RWJ; Dick AD; Pawade J
    Acta Ophthalmol; 2019 Feb; 97(1):e138-e139. PubMed ID: 30113125
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate.
    Saleh M; Nikolitch K; Bourcier T; Speeg C; Gaucher D
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):761-4. PubMed ID: 21755434
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoplastic lymphomatous submaculopathy.
    Testi I; Agarwal A; Gupta V;
    Indian J Ophthalmol; 2019 Dec; 67(12):2051-2052. PubMed ID: 31755451
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
    Kim RY; Park JH; Kim M; Park YG; Cho SG; Park YH
    PLoS One; 2021; 16(11):e0260469. PubMed ID: 34813633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.